RAB7B and cancer: DCs isolated from healthy donors were successfully depleted for Rab7b (Fig. S2A,B), loaded with a specific cancer peptide (a TGFBR2 frameshift mutation-derived epitope), and further incubated with autologous T cells transfected with the validated cognate T cell receptor (TCR), Radium-1 (Inderberg et al., 2017).